
Valitse etikettisi
näkyy suoraan injektiopullossaLaboratorioraportti
PDF- Testattu
- GHK-Cu + KPV Blend 60mg
- Laboratorio
- Analiza Białek
- Päivämäärä
- October 2026
- Tulos
- 99% purity (GHK-Cu 95.54 mg + KPV 10.91 mg, 50 + 10 mg label)
- Endotoksiinit
- 6.88 EU/vial
- Tilauksen nro
- Salasana
Testattu riippumattomasti, tarkistettavissa salasanalla suoraan laboratoriossa.
GHK-Cu + KPV Blend
Healing
- Laboratoriotestattu · 99 % puhtaus
- Lähetetään Saksasta
Tilaus
- DHL seurannalla
- Huomaamaton pakkaus
Yhdellä silmäyksellä
GHK-Cu + KPV Blend lukuina
Tietopankkimme keskeiset luvut.
Koko tietopankkiartikkeli- Type
- Blend of two tripeptidesGHK-Cu + KPV
- Use
- Subcutaneous injection after reconstitution
- Sizes
- 60 mg1 size in the shop
What studies show
All 7 sources in the lexicon- BioMed Research International
- Journal of Biomaterials Science, Polymer Edition
- Macromolecular Bioscience
Arvostelut
Mitä asiakkaat sanovat
Vain todelliset tilaukset, joissa oli GHK-Cu + KPV Blend.
Kaikki arvostelutTietoa
Kaikki aiheesta GHK-Cu + KPV Blend
Tarkemmat tiedot tulossa pian.
Annostelu
Ladataan annostelutietoja …
Tilaa samalla
Mitä tarvitset sen kanssa
Bakteriostaattinen vesi lisätään ostoskoriisi automaattisesti. Ruiskut ja pyyhkeet yhdellä napsautuksella.
Insuliiniruiskut
10 kpl · 5.50 €
Alkoholipyyhkeet
50 kpl · 10 €
Kuinka paljon vettä?
Ruiskun yksiköt injektiopullosi koolle.
Avaa laskuri →Are there studies on the GHK-Cu + KPV Blend?
No. As of 26 October 2026 there is no study on the blend, neither on ClinicalTrials.gov nor in PubMed. The only paper naming both peptides is a review of tripeptides in wound healing without its own data on the blend. Only the single components have been studied.
Why these two peptides?
The idea is that the pathways complement each other: GHK-Cu on the side of building and collagen, KPV on the side of calming inflammation. This has not been tested. No study has examined whether the combination does more than either substance alone.
What is known about GHK-Cu in humans?
The best study is a randomised gel trial in diabetic foot ulcers: a median 98.5 percent of the wound area closed, versus 60.8 percent with vehicle gel. Other data come mainly from cosmetics. A recent review calls the clinical evidence sparse, there are no studies on injection.
What is known about KPV?
KPV enters gut and immune cells via the transporter PepT1 and inhibits the inflammation pathway NF-κB there even at nanomolar concentrations. In two colitis models in mice KPV in the drinking water reduced inflammation. In nanoparticles a 12,000-fold lower concentration was enough. In skin cells KPV triggered a calcium signal. There are no human studies.
Which side effects are known?
There are no data for the blend. In the GHK-Cu gel trial 7 percent of ulcers became infected, versus 34 percent with vehicle gel. Human safety data are missing for KPV and for GHK-Cu as an injection. A review of peptides in sport warns that robust safety data are missing for many of these substances.
Is the blend approved?
No. Neither the blend nor GHK-Cu or KPV is approved as a medicine (as of October 2026). ChEMBL lists GHK without a clinical phase and no trial of KPV is registered.
Liittyvät
Samankaltaiset tuotteet
BPC-157
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
4 kokoa
Laboratoriotestattu
= alkaen 5.2 €/injektiopullo
TB-500 (Thymosin B4)
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
3 kokoa
Laboratoriotestattu
= alkaen 18.8 €/injektiopullo
TB-500 FRAG
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
1 koko
= 24.8 €/injektiopullo
BPC + TB Blend
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
3 kokoa
Laboratoriotestattu
= alkaen 24.8 €/injektiopullo
GHK-Cu + KPV Blend